北卡罗来纳州研究三角园,2024年10月24日(环球新swire)—BioCryst制药公司(纳斯达克股票代码: BCRX)今日宣布关于口服ORLADEYO每日一次的新实际世界比较研究。 GlobeNewswire10/24 20:00 派杰投资维持BioCryst制药(BCRX.US)买入评级,维持目标价20美元 派杰投资分析师Christopher Raymond维持$BioCryst Pharmaceuticals(BCRX.US...
BioCryst制药 | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(10.02%) 11/07 23:53 BioCryst制药 | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(9.81%) 11/07 23:28 BioCryst制药 | 10-Q:2024财年三季报 11/06 06:21 BioCryst制药 | SC 13G/A:超过5%持股股东披露文...
One big tech stock could profit from Super Micro’s disaster Super Micro Computer's slate of problems could boost rivals. SMCIDELLHPE Investing News, Analysis, and Tips 2 hours ago Stock Market Today: Stocks end at record highs in post-Trump rally; Tesla tops $1 trillion ...
Over the last 52 weeks, BCRX has been trading between $4.55 and $13.65. More recently in the last 4 weeks, the stock has been trading between $12.10 and $12.90. Shares are up 149.27% y/y, and 80.39% year-to-date. BioCryst Pharmaceuticals, Inc., is a biotech company, which designs ...
Learn more › Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. View Premium Services
Investing News, Analysis, and Tips 18 hours ago Analysts revisit Applied Materials stock price targets after Q4 earnings Applied Materials, the biggest U.S. chip-equipment maker, is a key player in the AI and broader semiconductor space. ...